Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 58 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 3345. Clear
Clear
Q1
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Alcohol and Drug Abuse, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q1
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy
View →
Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
FIERCE GOVERNMENT RELATIONS for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Health Issues
View →
Q1
OLIN CORPORATION for OLIN CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · Missouri · House · Senate
Chemicals/Chemical Industry, Transportation, Firearms/Guns/Ammunition, Health Issues
View →
Q1
CAMBIA HEALTH SOLUTIONS for CAMBIA HEALTH SOLUTIONS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid
View →
Q1
LUNDBECK LLC for LUNDBECK LLC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q1
INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE
1st Quarter (Jan 1 - Mar 31) 2026 · Wisconsin · House · Senate
Pharmacy
View →
Q1
DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income
Pharmacy
View →
Q1
E3 STRATEGIC CONSULTING GROUP for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · $60,000.00 income
Pharmacy
View →
Q1
DAVE KOLBE CONSULTING for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · $30,000.00 income
Pharmacy
View →
Q4
EMD SERONO, INC. for EMD SERONO INC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Veterans, Defense, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q4
CAROL G HOLLADAY & ASSOCIATES for SOUTHEAST GEORGIA HOSPITAL SYSTEM
4th Quarter (Oct 1 - Dec 31) 2025 · Georgia · House · Senate · $18,000.00 income
Budget/Appropriations, Health Issues, Veterans
View →
Q4
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q4
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate
Labor Issues/Antitrust/Workplace, Defense, Alcohol and Drug Abuse, Medicare/Medicaid
View →
Q4
CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Pharmacy, Taxation/Internal Revenue Code, Medicare/Medicaid, Insurance
View →
Q4
THE MCMANUS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q4
FIERCE GOVERNMENT RELATIONS for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues
View →
Q4
AMGEN, INC. for AMGEN INC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q4
RED+BLUE STRATEGIES for CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP)
4th Quarter (Oct 1 - Dec 31) 2025 · Oregon · House · Senate · $80,000.00 income
Health Issues, Medicare/Medicaid
View →
Q4
NATIONAL ASSOCIATION OF CHAIN DRUG STORES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate
Pharmacy, Medicare/Medicaid, Budget/Appropriations
View →
Q4
FOOD MARKETPLACE INC. for FOOD MARKETPLACE INC
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate
Agriculture, Consumer Issues/Safety/Products, Environment/Superfund, Food Industry (safety, labeling, etc.)
View →
Q4
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy
View →
Q4
LUNDBECK LLC for LUNDBECK LLC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q4
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Previous Page 2 of 3 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem